Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee
Clin Mol Hepatol 2025;31(4):1285-1297. Published online June 13, 2025
Background/Aims Hepatocellular carcinoma (HCC) frequently recurs after curative treatment, posing challenges to long-term survival. Although contrast-enhanced multiphasic computed tomography (CECT) is commonly used for detecting recurrence, it is associated with risks such as radiation exposure and contrast agent reactions. This study aimed to compare the diagnostic performance of non-contrast magnetic resonance imaging (NC-MRI) with CECT for detecting recurrent HCC.
Methods In this prospective multicenter intra-individual head-to-head comparison trial (study identifier: NCT05690451, KCT0006395), participants who had undergone curative treatment for HCC and remained recurrence-free for over two years were enrolled. Each participant underwent three follow-up imaging sessions at 2–6-month intervals using both CECT and NC-MRI. The primary outcome was the detection accuracy of each modality, analyzed using the generalized estimating equation analysis. Secondary outcomes included sensitivity and specificity.
Results The study included 203 participants with a total of 528 paired imaging sessions, identifying recurrent HCC in 22 cases (10.8%). Among these, 21 cases involved intrahepatic recurrence with a median tumor size of 1.3 cm, and one case had aortocaval lymph node metastasis. NC-MRI achieved a detection accuracy of 96.6% (196/203), higher than CECT’s 91.6% (186/203) (P=0.006). NC-MRI also showed greater sensitivity (77.3% [17/22] vs. 36.4% [8/22]; P=0.012), while specificity was comparable between NC-MRI and CECT (98.9% [179/181] vs. 98.3% [178/181]; P=0.999).
Conclusions NC-MRI demonstrated higher sensitivity and accuracy compared to CECT in detecting recurrent HCC in patients who had been disease-free for over two years following curative treatment, indicating its potential as a preferred imaging modality for this purpose.
Citations
Citations to this article as recorded by
Non-contrast magnetic resonance imaging outperforms contrast-enhanced computed tomography in preoperative detection of hepatocellular carcinoma: A paired validation study Laizhu Zhang, Weiwei Zong, Jialin Gao, Huan Li, Leizhou Xia, Xiaoli Mai, Jun Chen, Binghua Li, Decai Yu Clinical and Molecular Hepatology.2026; 32(1): e34. CrossRef
Updates in Abbreviated MRI‐Based HCC Surveillance Hyo Jung Park, So Yeon Kim, Young‐Suk Lim Journal of Gastroenterology and Hepatology.2026; 41(3): 914. CrossRef
Moving beyond Ultrasound for Hepatocellular Carcinoma Surveillance in High-Risk Patients with Chronic Hepatitis B Hae Lim Lee Gut and Liver.2026; 20(2): 174. CrossRef
Correspondence to editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography” Dong Ho Lee Clinical and Molecular Hepatology.2026; 32(2): e221. CrossRef
Correspondence to letter to the editor on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography” Dong Ho Lee Clinical and Molecular Hepatology.2026; 32(2): e251. CrossRef
Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treat Qi-Feng Chen, Sui-Xing Zhong, Ming Zhao Clinical and Molecular Hepatology.2026; 32(2): e175. CrossRef
Interreader Agreement for Individual Ancillary Features in LI-RADS CT/MRI Version 2018: A Systematic Review and Meta-Analysis Yong Jun Jung, Sang Hyun Choi, Subin Heo, Dong Hwan Kim, Suk Kim, Seung Baek Hong American Journal of Roentgenology.2026;[Epub] CrossRef
HCC surveillance after curative treatment: A new frontier for abbreviated MRI: Editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to Hyungjin Rhee, Jin-Young Choi Clinical and Molecular Hepatology.2026; 32(2): 939. CrossRef
Revisiting the role of non-contrast MRI in recurrent HCC: Bridging diagnostic performance and real-world applicability: Letter to the editor on “Non-contrast MRI for detection of late recurrent hepatocellular carcinoma after curative treatment: A prospect Lu Sun, Xin Zhang Clinical and Molecular Hepatology.2026; 32(2): e172. CrossRef
Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol Hyo Jung Park, Dong Ho Lee, Won Chang, Hae Young Kim, Dong Hwan Kim, Won-Mook Choi, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Young-Suk Lim, Seon-Ok Kim, Amit G Singal, So Yeon Kim BMJ Open.2026; 16(4): e116809. CrossRef
The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance Jianwei Chen, Yuemin Zhu, Dechun Zheng, Liting Wen, Juyi Wu, Qiuyuan Yue, Zhuting Fang Journal of Magnetic Resonance Imaging.2026;[Epub] CrossRef
Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD Cirrhosis Mohammad Jarrah, Sneha Deodhar, Lisa Quirk, Mohammed Al-Hasan, Ashish Sharma, Guruveer Bhamra, Julia Terrell, Fasiha Kanwal, Yujin Hoshida, Nicole E. Rich, Purva Gopal, Amit G. Singal Cancers.2025; 17(23): 3835. CrossRef
Background/Aims The prediction of clinical outcomes in patients with chronic hepatitis B (CHB) is paramount for effective management. This study aimed to evaluate the prognostic value of computed tomography (CT) analysis using deep learning algorithms in patients with CHB. Methods: This retrospective study included 2,169 patients with CHB without hepatic decompensation who underwent contrast-enhanced abdominal CT for hepatocellular carcinoma (HCC) surveillance between January 2005 and June 2016. Liver and spleen volumes and body composition measurements including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and skeletal muscle indices were acquired from CT images using deep learning-based fully automated organ segmentation algorithms. We assessed the significant predictors of HCC, hepatic decompensation, diabetes mellitus (DM), and overall survival (OS) using Cox proportional hazard analyses. Results: During a median follow-up period of 103.0 months, HCC (n=134, 6.2%), hepatic decompensation (n=103, 4.7%), DM (n=432, 19.9%), and death (n=120, 5.5%) occurred. According to the multivariate analysis, standardized spleen volume significantly predicted HCC development (hazard ratio [HR]=1.01, P=0.025), along with age, sex, albumin and platelet count. Standardized spleen volume (HR=1.01, P<0.001) and VAT index (HR=0.98, P=0.004) were significantly associated with hepatic decompensation along with age and albumin. Furthermore, VAT index (HR=1.01, P=0.001) and standardized spleen volume (HR=1.01, P=0.001) were significant predictors for DM, along with sex, age, and albumin. SAT index (HR=0.99, P=0.004) was significantly associated with OS, along with age, albumin, and MELD. Conclusions: Deep learning-based automatically measured spleen volume, VAT, and SAT indices may provide various prognostic information in patients with CHB.
Citations
Citations to this article as recorded by
Artificial intelligence prognostication of liver disease using imaging Manil D Chouhan, Kate McLean, James A Thomas, Jason Dowling British Journal of Radiology.2026; 99(1182): 1036. CrossRef
The atlas of abdominal organ remodeling in hepatocellular carcinoma patients: An artificial intelligence-based multicenter imaging study Yusheng Guo, Xiaona Fu, Tianxiang Li, Ning Wang, Shanshan Jiang, Shanmei Li, Xiaofang Guo, Rundong Wang, Shichao Long, Mengsi Li, Qiuping Liu, Kai Zhao, Yangyang Xie, Xuejun Chen, Lixia Wang, Chuansheng Zheng, Lian Yang Med.2026; 7(7): 101176. CrossRef
Dynamic changes in visceral fat density and skeletal muscle index predict new-onset decompensation in chronic hepatitis B-related cirrhosis Xiaoyue Zhang, Zheyu Li, Cuifang He, Shangwen Hu, Yirui Hu, Huixia Zhang, Qianhui Gao, Wanchun Qiu, Wenqiang He, Zhenxia Huang, Meiling Zhang, Jiale Lu, Liting Zhang, Junfeng Li Hepatobiliary Communications.2026; 1(1): 100003. CrossRef
Routine laboratory model for identifying significant fibrosis in chronic hepatitis B Ting-Ting Wang, Yi-Li Chu, Yi-Qiang Lou, Rou-Yi Yang, Mao-Mao Pu, Lian-Jiang Shan, Lu Huang, Shan-Shan Chen, Hai-Jun Huang World Journal of Hepatology.2026;[Epub] CrossRef
Automated analysis of abdominal body composition using MRI: algorithm development and validation via CT comparison S.K. Jeon, I. Joo, J.M. Lee, J.-M. Kim, H.-J. Chung, S.J. Park Clinical Radiology.2026; 100: 107437. CrossRef
Reply to: “A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?” Moon Haeng Hur, Jeong-Hoon Lee Journal of Hepatology.2025; 82(3): e143. CrossRef
Early prediction of adverse outcomes in liver cirrhosis using a CT-based multimodal deep learning model Nanai Xie, Yiwen Liang, Zixin Luo, Jing Hu, Ruiquan Ge, Xiang Wan, Changmiao Wang, Guannan Zou, Feng Guo, Yi Jiang Abdominal Radiology.2025; 51(1): 137. CrossRef
Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients” Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong Clinical and Molecular Hepatology.2024; 30(4): 994. CrossRef
Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on “Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection” Yong Eun Chung Clinical and Molecular Hepatology.2024; 30(4): 669. CrossRef
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B pati Beom Kyung Kim Clinical and Molecular Hepatology.2024; 30(4): 656. CrossRef
Assessment of body composition and prediction of infectious pancreatic necrosis via non-contrast CT radiomics and deep learning Bingyao Huang, Yi Gao, Lina Wu Frontiers in Microbiology.2024;[Epub] CrossRef
First
Prev
